Literature DB >> 34674600

N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.

Yiling Ge1, Tong Liu1, Chuntao Wang2, Yanqiu Zhang3, Siyi Xu1, Yiyi Ren1, Yanlu Feng1, Lihong Yin1, Yuepu Pu1, Geyu Liang1.   

Abstract

As one of the most common forms of RNA modification, N6-methyladenosine (m6A) RNA modification has attracted increasing research interest in recent years. This reversible RNA modification added a new dimension to the post-transcriptional regulation of gene expression. In colorectal cancer (CRC), the role of m6A modification has been extensively studied, not only on mRNAs but also on non-coding RNAs (ncRNAs). In the present review, we depicted the role of m6A modification in CRC, systematically elaborate the interaction between m6A modification and regulatory ncRNAs in function and mechanism. Moreover, we discussed the potential applications in clinical.

Entities:  

Keywords:  N6-methyladenosine (m6A); RNA modification; cancer progression; colorectal cancer (CRC); non-coding rnas (ncRNAs)

Mesh:

Substances:

Year:  2021        PMID: 34674600      PMCID: PMC8782171          DOI: 10.1080/15476286.2021.1974749

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.766


  94 in total

1.  N6-methyladenosine methyltransferase METTL3 promotes colorectal cancer cell proliferation through enhancing MYC expression.

Authors:  Song Xiang; Xiaolong Liang; Shuo Yin; Jian Liu; Zheng Xiang
Journal:  Am J Transl Res       Date:  2020-05-15       Impact factor: 4.060

2.  m6 A RNA methylation regulators contribute to malignant progression in rectal cancer.

Authors:  Jinfu Zhuang; Chunlin Lin; Jianxin Ye
Journal:  J Cell Physiol       Date:  2020-02-11       Impact factor: 6.384

3.  RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated.

Authors:  Atsushi Tanabe; Kenya Tanikawa; Mai Tsunetomi; Kaori Takai; Hiroto Ikeda; Junpei Konno; Toshihiko Torigoe; Hideki Maeda; Goro Kutomi; Kenji Okita; Mitsuru Mori; Hiroeki Sahara
Journal:  Cancer Lett       Date:  2016-03-17       Impact factor: 8.679

Review 4.  m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer.

Authors:  Huilin Huang; Hengyou Weng; Jianjun Chen
Journal:  Cancer Cell       Date:  2020-03-16       Impact factor: 31.743

5.  Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases.

Authors:  Ping Wang; Katelyn A Doxtader; Yunsun Nam
Journal:  Mol Cell       Date:  2016-06-30       Impact factor: 17.970

6.  Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome.

Authors:  Bastian Linder; Anya V Grozhik; Anthony O Olarerin-George; Cem Meydan; Christopher E Mason; Samie R Jaffrey
Journal:  Nat Methods       Date:  2015-06-29       Impact factor: 28.547

7.  AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells.

Authors:  Yuko Ueda; Ikumi Ooshio; Yasuyuki Fusamae; Kaori Kitae; Megumi Kawaguchi; Kentaro Jingushi; Hiroaki Hase; Kazuo Harada; Kazumasa Hirata; Kazutake Tsujikawa
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

8.  Exploration of Potential Roles of m6A Regulators in Colorectal Cancer Prognosis.

Authors:  Liechen Ji; Shuo Chen; Liqiang Gu; Xipeng Zhang
Journal:  Front Oncol       Date:  2020-05-15       Impact factor: 6.244

9.  LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification.

Authors:  Pingfu Hou; Sen Meng; Minle Li; Tian Lin; Sufang Chu; Zhongwei Li; Junnian Zheng; Yuming Gu; Jin Bai
Journal:  J Exp Clin Cancer Res       Date:  2021-02-01

10.  Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis.

Authors:  Zeyan Zhang; Qianfu Gao; Shanchao Wang
Journal:  J Cell Mol Med       Date:  2021-02-02       Impact factor: 5.310

View more
  2 in total

Review 1.  Research Progress of RNA Methylation Modification in Colorectal Cancer.

Authors:  Weizheng Liang; Hongyang Yi; Chenyu Mao; Qingxue Meng; Xueliang Wu; Shanliang Li; Jun Xue
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

2.  The Role of N6-Methyladenosine-Associated lncRNAs in the Immune Microenvironment and Prognosis of Colorectal Cancer.

Authors:  Congfei Yuan; Caidong Liu; Shuli Zhao; Xishan Zhang; Haifeng Jia; Baiyu Chen; Maojin Zhang; Yuan Zheng; Jin Zhou; Yanzhi Bo
Journal:  J Oncol       Date:  2022-09-06       Impact factor: 4.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.